Activated memory CD4+ T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6661-6669

  Mattapallil, Joseph J ^a,b   Smit McBride, Zeljka ^a,b   Dailey, Peter ^a,b   Dandekar, Satya ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 2; TENOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CYTOKINE PRODUCTION; HELPER CELL; IMMUNOPHENOTYPING; INTESTINE MUCOSA; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0032775218     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6661-6669.1999     Document Type: Article

References (49)

1. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
2. Banmerach, A. N. P., and N. Cerf-Bensussan. 1996. Adhesion molecules on mucosal T lymphocytes, p. 263-274. In M. Kagnoff and H. Kiyono (ed.), Essentials of mucosal immunology. Academic Press, Inc., San Diego, Calif.
3. Biglino, A., A. Pugliese, B. Forno, A. M. Pollono, M. Busso, and P. Gioannini. 1991. Effects of long-term zidovudine treatment on cell-mediated immune response and lymphokine production. J. Acquired Immune Defic. Syndr. 4:261-266.
4. Brinchmann, J. E., J. H. Dobloug, B. H. Heger, L. L. Haaheim, M. Sannes, and T. Egeland. 1994. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 169:730-738.
5. Clerici, M., A. L. Landay, H. A. Kessler, J. P. Phair, D. J. Venzon, C. W. Hendrix, D. R. Lucey, and G. M. Shearer. 1992. Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. J. Infect. Dis. 164:723-730.
6. Clerici, M., E. Roilides, K. M. Butler, L. DePalma, D. Venzon, G. M. Shearer, and P. A. Pizzo. 1992. Changes in T-helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity. Blood 80:2196-2202.
7. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Investig. 84:1892-1899.
8. Clerici, M., C. S. Via, D. R. Lucey, E. Roilides, P. A. Pizzo, and G. M. Shearer. 1991. Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur. J. Immunol. 21:665-670.
9. Dadaglio, G., F. Michel, P. Langlade-Demoyen, P. Sansonetti, D. Chevrier, F. Vuillier, F. Plata, and A. Hoffenbach. 1992. Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment. Clin. Exp. Immunol. 87:7-14.
10. Dolan, M. J., M. Clerici, S. P. Blatt, C. W. Hendrix, G. P. Melcher, R. N. Boswell, T. M. Freeman, W. Ward, R. Hensley, and G. M. Shearer. 1995. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 172:79-87.
11. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 373:255-257.
12. French, M. A., S. A. Mallal, and R. L. Dawkins. 1992. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 6:1293-1297.
13. Graters, R. A., F. G. Terpstra, R. De Jong, C. J. Van Noesel, R. A. Van Lier, and F. Miedema. 1990. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20:1039-1044.
14. Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734-739.
15. Hammer, S. M., K. E. Squires, M. D. Hughes, J. M. Grimes, L. M. Demeter, J. S. Currier, J. J. Eron, Jr., J. E. Feinberg, H. H. Balfour, Jr., L. R. Deyton, J. A. Chodakewitz, and M. A. Fischl. 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337:725-733.
16. Harris, M., P. Patenaude, P. Cooperberg, D. Filipenko, A. Thorne, J. Raboud, S. Rae, P. Dailey, D. Chernoff, J. Todd, B. Conway, and J. S. Montaner. 1997. Correlation of virus load in plasma and lymph node tissue in human immunodeficiency virus infection. INCAS Study Group. J. Infect. Dis. 176:1388-1392.
17. Heise, C., C. J. Miller, A. Lackner, and S. Dandekar. 1994. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J. Infect. Dis. 169:1116-1120.
18. Heise, C., P. Vogel, C. J. Miller, A. Lackner, and S. Dandekar. 1993. Distribution of SIV infection in the gastrointestinal tract of rhesus macaques at early and terminal stages of AIDS. J. Med. Primatol. 22:187-193.
19. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
20. Kanamori, Y., K. Ishimaru, M. Nanno, K. Maki, K. Ikuta, H. Nariuchi, and H. Ishikawa. 1996. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J. Exp. Med. 184:1449-1459.
21. Kelleher, A. D., A. Carr, J. Zaundsrs, and D. A. Cooper. 1996. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. 173:321-329.
22. Klein, S. A., J. M. Dobmeyer, T. S. Dobmeyer, M. Pape, O. G. Ottmann, E. B. Helm, D. Hoelzer, and R. Rossol. 1997. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11:1111-1118.
23. Kotler, D. P., T. Shimada, G. Snow, G. Winson, W. Chen, M. Zhao, Y. Inada, and F. Clayton. 1998. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS 12:597-604.
24. Krowka, J. F., D. P. Stiles, S. Jain, K. S. Steimer, C. George-Nascimento, A. Gyenes, P. J. Barr, H. Hollander, A. R. Moss, J. M. Homsy, et al. 1989. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J. Clin. Investig. 83:1198-1203.
25. Landay, A. L., J. Bethel, and S. Schnittman. 1998. Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res. Hum. Retroviruses 14:445-451.
26. Lane, H. C., H. Masur, E. P. Gelmann, D. L. Longo, R. G. Steis, T. Chused, G. Whalen, L. C. Edgar, and A. S. Fauci. 1985. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am. J. Med. 78:417-422.
27. Maric, D., D. Kaiserlian, and K. Croitoru. 1996. Intestinal epithelial cell line induction of T cell differentiation from bone marrow precursors. Cell. Immunol. 172:172-179.
28. + progenitor cells in contrast to thymus during primary simian immunodeficiency virus infection. J. Virol. 73:4518-4523.
29. + T-cell depletion in primary simian immunodeficiency virus infection. J. Virol. 72:6421-6429.
30. McClure, H. M., D. C. Anderson. A. A. Ansari, P. N. Fultz, S. A. Klumpp, and R. F. Schinazi. 1990. Nonhuman primate models for evaluation of AIDS therapy. Ann. N. Y. Acad. Sci. 616:287-298.
31. Miedema, F., A. J. Petit, F. G. Terpstra, J. K. Schattenkerk, F. de Wolf, B. J. Al, M. Roos, J. M. Lange, S. A. Danner, J. Goudsmit, et al. 1988. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J. Clin. Investig. 82:1908-1914.
32. Mosier, D. E. 1995. HIV results in the frame. CD4+ cell turnover. Nature 375:193-194.
33. Mosley, R. L., and J. R. Klein. 1992. Peripheral engraftment of fetal intestine into athymic mice sponsors T cell development: direct evidence for thymopoietic function of murine small intestine. J. Exp. Med. 176:1365-1373.
34. Nye, K. E., K. A. Knox, and A. J. Pinching. 1991. Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy. AIDS 5:413-417.
35. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S. J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, et al. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retroviral. 8:446-454.
36. Pakker, N. G., D. W. Notermans, R. J. de Boer, M. T. Roos, F. de Wolf, A. Hill, J. M. Leonard, S. A. Danner, F. Miedema, and P. T. Schellekens. 1998. Diphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 4:208-214.
37. Rinaldo, C., X. L. Huang, P. Piazza, J. Armstrong, G. Rappocciolo, G. Pazin, D. McMahon, P. Gupta, Z. Fan, Z. Zhang, et al. 1991. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J. Infect. Dis. 164:638-645.
38. Salmi, M., D. P. Andrew, E. C. Butcher, and S. Jalkanen. 1995. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J. Exp. Med. 181:137-149.
39. + T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72:6646-6656.
40. Sprent, J., and D. Tough. 1995. HIV results in the frame. CD4+ cell turnover. Nature 375:194.
41. Stone, J. D., C. C. Heise, D. R. Canfield, M. J. Elices, and S. Dandekar. 1995. Differences in viral distribution and cell adhesion molecule expression in the intestinal tract of rhesus macaques infected with pathogenic and nonpathogenic SIV. J. Med. Primatol. 24:132-140.
42. Stone, J. D., C. C. Heise, C. J. Miller, C. H. Halsted, and S. Dandekar. 1994. Development of malabsorption and nutritional complications in simian immunodeficiency virus-infected rhesus macaques. AIDS 8:1245-1256.
43. Tsai, C. C., K. E. Follis, T. W. Beck, A. Sabo, N. Bischofberger, and P. J. Dailey. 1997. Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques. AIDS Res. Hum. Retroviruses 13:707-712.
44. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 270:1197-1199.
45. Van Rompay, K. K., J. M. Cherrington, M. L. Marthas, C. J. Berardi, A. S. Mulato, A. Spinner, R. P. Tarara, D. R. Canfield, S. Telm, N. Bischofberger, and N. C. Pedersen, 1996. 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob. Agents Chemother. 40:2586-2591.
46. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, P. R. Johnson, C. R. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427-431.
47. Walker, R. E., C. S. Carter, L. Muul, V. Natrajan, B. H. Herpin, S. F. Leitman, H. G. Klein, C. A. Mullen, J. A. Metcalf, M. Baseler, J. Falloon, R. T. Davey, Jr., J. A. Kovacs, M. A. Polis, H. Masur, R. M. Blaese, and H. C. Lane. 1998. Peripheral expansion of preexisting mature T cells is an important means of CD4+ T cell regeneration in HIV infected patients. Nat. Med. 4:852-856.
48. Yarchoan, R., H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman, C. F. Perno, K. S. Marczyk, J. P. Allain, D. G. Johns, and S. Broder. 1989. In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245:412-415.
49. Zidek, Z., A. Holy, and D. Frankova. 1997. Amiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cylokine and nitric oxide production. Eur. J. Pharmacol. 331:245-252.